We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
X
201
DELISTED
US Steel
X
| $56.9M | 0.13% |
3,235,338
+2,006,222
| +163% | +$54.8M |
|
202
ON Semiconductor
ON
$31.6B
| $56.8M | 0.13% |
1,146,419
-98,302
| -8% | -$5.48M |
|
203
Qorvo
QRVO
$8.74B
| $56.4M | 0.13% |
605,272
-37,727
| -6% | -$4.07M |
|
204
Xcel Energy
XEL
$48.8B
| $55.8M | 0.13% |
792,151
-8,313
| -1% | -$605K |
|
205
JB Hunt Transport Services
JBHT
$25.2B
| $55.1M | 0.12% |
356,022
-21,334
| -6% | -$3.61M |
|
206
J.M. Smucker
SJM
$12.8B
| $54.5M | 0.12% |
425,997
-88,167
| -17% | -$11.8M |
|
207
First American
FAF
$7.58B
| $54.3M | 0.12% |
1,048,466
+311,624
| +42% | +$18.1M |
|
208
Celanese
CE
$4.82B
| $54.1M | 0.12% |
465,898
+44,154
| +10% | +$6.34M |
|
209
McDonald's
MCD
$195B
| $54M | 0.12% |
218,845
-269,894
| -55% | -$66.5M |
|
210
Skyworks Solutions
SWKS
$10.6B
| $53.9M | 0.12% |
591,475
+75,400
| +15% | +$8.14M |
|
211
Hartford Financial Services
HIG
$39.3B
| $53.4M | 0.12% |
836,908
+90,588
| +12% | +$6.35M |
|
212
Marathon Petroleum
MPC
$83.7B
| $53.3M | 0.12% |
648,494
+337,096
| +108% | +$31.5M |
|
213
Kohl's
KSS
$2.19B
| $53.2M | 0.12% |
1,533,324
+1,064,040
| +227% | +$52.2M |
|
214
Dover
DOV
$28.4B
| $53.1M | 0.12% |
443,187
-97,836
| -18% | -$13.2M |
|
|
HOLX
215
DELISTED
Hologic
HOLX
| $53M | 0.12% |
764,132
-190,512
| -20% | -$14.1M |
|
216
Cardinal Health
CAH
$55.4B
| $52.8M | 0.12% |
1,009,330
+18,348
| +2% | +$1.04M |
|
217
Texas Roadhouse
TXRH
$13.7B
| $52.5M | 0.12% |
716,956
-37,232
| -5% | -$2.93M |
|
218
Henry Schein
HSIC
$9.82B
| $51.6M | 0.12% |
678,117
+30,868
| +5% | +$2.59M |
|
219
Emcor
EME
$36B
| $51.5M | 0.12% |
511,829
+108,045
| +27% | +$11.6M |
|
|
MASI
220
DELISTED
Masimo
MASI
| $51.2M | 0.12% |
391,742
+186,366
| +91% | +$24.9M |
|
221
Pentair
PNR
$11B
| $51.1M | 0.12% |
1,142,627
+367,437
| +47% | +$18.4M |
|
222
IBM
IBM
$224B
| $50.7M | 0.11% |
363,356
-416,355
| -53% | -$56.2M |
|
223
Sherwin-Williams
SHW
$89.8B
| $50.3M | 0.11% |
228,569
-87,191
| -28% | -$22.4M |
|
224
PVH
PVH
$4.04B
| $50M | 0.11% |
894,415
+486,888
| +119% | +$33.7M |
|
225
Amkor Technology
AMKR
$13.7B
| $49.3M | 0.11% |
2,954,554
+656,355
| +29% | +$12.5M |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.